CN105695350B - Saccharomyces cerevisiae and method for producing glucosamine by using saccharomyces cerevisiae - Google Patents
Saccharomyces cerevisiae and method for producing glucosamine by using saccharomyces cerevisiae Download PDFInfo
- Publication number
- CN105695350B CN105695350B CN201610168668.6A CN201610168668A CN105695350B CN 105695350 B CN105695350 B CN 105695350B CN 201610168668 A CN201610168668 A CN 201610168668A CN 105695350 B CN105695350 B CN 105695350B
- Authority
- CN
- China
- Prior art keywords
- fermentation
- culture medium
- glucosamine
- saccharomyces cerevisiae
- seed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 title claims abstract description 80
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 title claims abstract description 73
- 229960002442 glucosamine Drugs 0.000 title claims abstract description 58
- 240000004808 Saccharomyces cerevisiae Species 0.000 title claims abstract description 47
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 title claims abstract description 47
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 21
- 238000000855 fermentation Methods 0.000 claims abstract description 81
- 230000004151 fermentation Effects 0.000 claims abstract description 81
- 239000001963 growth medium Substances 0.000 claims abstract description 53
- 238000011218 seed culture Methods 0.000 claims abstract description 41
- OOYGSFOGFJDDHP-KMCOLRRFSA-N kanamycin A sulfate Chemical compound OS(O)(=O)=O.O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N OOYGSFOGFJDDHP-KMCOLRRFSA-N 0.000 claims abstract description 24
- 229960002064 kanamycin sulfate Drugs 0.000 claims abstract description 24
- 238000012258 culturing Methods 0.000 claims abstract description 13
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 12
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000008101 lactose Substances 0.000 claims abstract description 12
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 12
- 239000001301 oxygen Substances 0.000 claims abstract description 12
- 238000009629 microbiological culture Methods 0.000 claims abstract description 4
- 239000002609 medium Substances 0.000 claims description 31
- 239000000706 filtrate Substances 0.000 claims description 25
- 239000000243 solution Substances 0.000 claims description 25
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 20
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 claims description 20
- 239000006228 supernatant Substances 0.000 claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 13
- 238000010828 elution Methods 0.000 claims description 13
- 239000008103 glucose Substances 0.000 claims description 13
- 239000002253 acid Substances 0.000 claims description 12
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 10
- 240000008042 Zea mays Species 0.000 claims description 10
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 10
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 10
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 10
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims description 10
- 235000011130 ammonium sulphate Nutrition 0.000 claims description 10
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 10
- 229940041514 candida albicans extract Drugs 0.000 claims description 10
- 235000005822 corn Nutrition 0.000 claims description 10
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 claims description 10
- 229940061634 magnesium sulfate heptahydrate Drugs 0.000 claims description 10
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 10
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 10
- 235000010344 sodium nitrate Nutrition 0.000 claims description 10
- 239000004317 sodium nitrate Substances 0.000 claims description 10
- 239000011550 stock solution Substances 0.000 claims description 10
- 239000012138 yeast extract Substances 0.000 claims description 10
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 claims description 9
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims description 9
- 238000009423 ventilation Methods 0.000 claims description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 8
- 230000001276 controlling effect Effects 0.000 claims description 8
- 239000013078 crystal Substances 0.000 claims description 8
- 238000004321 preservation Methods 0.000 claims description 7
- 230000010261 cell growth Effects 0.000 claims description 6
- 229920001817 Agar Polymers 0.000 claims description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 5
- 239000008272 agar Substances 0.000 claims description 5
- 239000003480 eluent Substances 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000011081 inoculation Methods 0.000 claims description 5
- 230000001105 regulatory effect Effects 0.000 claims description 5
- 239000011347 resin Substances 0.000 claims description 5
- 229920005989 resin Polymers 0.000 claims description 5
- 238000000967 suction filtration Methods 0.000 claims description 5
- 239000012137 tryptone Substances 0.000 claims description 5
- -1 5-10 g/L Substances 0.000 claims description 4
- 230000001580 bacterial effect Effects 0.000 claims description 4
- 239000007789 gas Substances 0.000 claims description 4
- 239000011780 sodium chloride Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 3
- 125000002091 cationic group Chemical group 0.000 claims description 2
- 239000007788 liquid Substances 0.000 abstract description 3
- 238000011217 control strategy Methods 0.000 abstract description 2
- FZHXIRIBWMQPQF-UHFFFAOYSA-N Glc-NH2 Natural products O=CC(N)C(O)C(O)C(O)CO FZHXIRIBWMQPQF-UHFFFAOYSA-N 0.000 description 14
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 7
- OVRNDRQMDRJTHS-RTRLPJTCSA-N N-acetyl-D-glucosamine Chemical compound CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-RTRLPJTCSA-N 0.000 description 7
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 7
- 241001052560 Thallis Species 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- YRKCREAYFQTBPV-UHFFFAOYSA-N acetylacetone Chemical compound CC(=O)CC(C)=O YRKCREAYFQTBPV-UHFFFAOYSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 210000000845 cartilage Anatomy 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000003834 intracellular effect Effects 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 3
- MTDHILKWIRSIHB-UHFFFAOYSA-N (5-azaniumyl-3,4,6-trihydroxyoxan-2-yl)methyl sulfate Chemical compound NC1C(O)OC(COS(O)(=O)=O)C(O)C1O MTDHILKWIRSIHB-UHFFFAOYSA-N 0.000 description 3
- 102000016611 Proteoglycans Human genes 0.000 description 3
- 108010067787 Proteoglycans Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000001768 cations Chemical class 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 229960002849 glucosamine sulfate Drugs 0.000 description 3
- 229920002674 hyaluronan Polymers 0.000 description 3
- 229960003160 hyaluronic acid Drugs 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 229920002101 Chitin Polymers 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- MSWZFWKMSRAUBD-QZABAPFNSA-N beta-D-glucosamine Chemical compound N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-QZABAPFNSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- SQXCNVUDTUUSNZ-KAQMDTKVSA-N (2r,3s,4r,5r)-2-amino-2,3,4,5,6-pentahydroxyhexanoic acid Chemical compound OC(=O)[C@@](O)(N)[C@@H](O)[C@H](O)[C@H](O)CO SQXCNVUDTUUSNZ-KAQMDTKVSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 102000000503 Collagen Type II Human genes 0.000 description 1
- 108010041390 Collagen Type II Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- DUKURNFHYQXCJG-UHFFFAOYSA-N Lewis A pentasaccharide Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(C)=O)C(OC2C(C(OC3C(OC(O)C(O)C3O)CO)OC(CO)C2O)O)OC1CO DUKURNFHYQXCJG-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 150000004263 amino monosaccharides Chemical class 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- YPTUAQWMBNZZRN-UHFFFAOYSA-N dimethylaminoboron Chemical compound [B]N(C)C YPTUAQWMBNZZRN-UHFFFAOYSA-N 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 239000005452 food preservative Substances 0.000 description 1
- 235000019249 food preservative Nutrition 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000020124 milk-based beverage Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 238000004816 paper chromatography Methods 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000013322 soy milk Nutrition 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229940126672 traditional medicines Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C12R2001/85—Saccharomyces
- C12R2001/865—Saccharomyces cerevisiae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
- C12N1/18—Baker's yeast; Brewer's yeast
- C12N1/185—Saccharomyces isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a saccharomyces cerevisiae and a method for producing glucosamine by the saccharomyces cerevisiae, wherein the saccharomyces cerevisiae is preserved in the China general microbiological culture Collection center. Seed culture: inoculating the saccharomyces cerevisiae into a slant culture medium containing kanamycin sulfate, culturing for 24-28 h, inoculating into a seed culture medium, and culturing to OD600When the value is 2-3, obtaining a seed culture solution; seed fermentation: inoculating the planting culture solution to a fermentation culture medium, and fermenting for 18-20 h to obtain a fermentation liquid; the volume of the seed culture solution inoculated to the fermentation culture medium is 1 to 2 percent of the volume of the fermentation culture medium; purifying and crystallizing the fermentation liquor to obtain the glucosamine. The invention optimizes the fermentation process of the mutagenized engineering strain, and determines that the yield of the glucosamine is obviously improved by implementing a lactose feeding strategy and a staged dissolved oxygen control strategy in the fermentation process.
Description
Technical Field
The invention relates to saccharomyces cerevisiae and a method for producing glucosamine by using the saccharomyces cerevisiae.
Background
Glucosamine (glucamine, or 2-amino-2-deoxy-D-glucose), the English abbreviation of which is GlcN, is a substituted compound in which the hydroxyl group at C at position 2 of glucose is substituted with an amino group, and the first amino monosaccharide to be confirmed is Glucosamine, which is a very important functional monosaccharide. The molecular formula of GlcN is C6H13O5N, molecular weight 179.17 g/mL. GlcN is found in many organisms, including bacteria, filamentous fungi, yeast, and even in plants and animals. Glucosamine is an important component of chitin, chitosan, and glycoprotein. Studies have also shown that glucosamine plays an important role in proteoglycans, all of which can be obtained from glucosamine by a certain amination. In addition, as a physiologically essential substance, it is also present in human connective tissues and is an important component necessary for the synthesis of proteoglycan in the matrix of human cartilage. The glucosamine has wide application and wide market prospect.
In 1876, glucosamine was first isolated from the hydrolysate of chitin, and in 1939, Walter Howski determined the spatial structure of glucosamine, from which glucosamine was better known and studied. At present, the united states is the largest country of consumption of glucosamine, and along with the improvement of income level and health care consciousness in china, the consumption of glucosamine is also in a trend of rapid increase year by year.
The application of glucosamine in the pharmaceutical industry is as follows:
glucosamine sulfate is a raw material drug for treating rheumatoid arthritis, and in recent years, glucosamine sulfate has various physiological functions of absorbing free radicals generated in a body, resisting aging, promoting weight loss, inhibiting bacteria, regulating endocrine of a human body and the like, so that glucosamine sulfate is widely used for production of food additives and health-care food. GlcN has a special therapeutic effect on arthritis by stimulating the biosynthesis of cartilage proteoglycan, and also increases the synthesis of cartilage-specific type II collagen, and has a hepatoprotective effect. Researches find that another GlcN derivative, acetylglucosamine GlcNAc, can induce K562 cells to differentiate towards macrophages, has obvious advantages in action concentration and action time compared with the traditional medicines, and is likely to become a novel cell differentiation induction medicine for clinical application because of small toxic and side effects.
The application of glucosamine in the food industry is as follows:
since GlcN is not toxic to human body, it is widely used as a food ingredient in both Japan and USA. Japan milk industry has begun selling GlcN-added milk beverage "Glucosamino Power" (family pack) since 2004 to 10 months, and Karl Pei, 2005 introduced
GlcN-added green tea beverage "FINESEPORT GLUCOSAMINE", other "GLUCOSAMINE soymilk" made from BAO JIU, and GlcN-added citrus beverage such as Dairy, Bojia, and ai Er Tai are also introduced into the market. Chenxin and the like research the antibacterial action of GlcN hydrochloride, and as a result, the found that the GlcN hydrochloride has obvious inhibition effect on common bacteria, mold and yeast in the tested food, wherein the bacteria are most sensitive, and the antibacterial action is gradually enhanced along with the increase of the concentration of the GlcN hydrochloride. Indicating that GlcN has broad prospects in becoming a novel natural food preservative.
Application of glucosamine in cosmetics
GlcNAc is a monomer of hyaluronic acid, is a basic composition unit of various important polysaccharides in organisms, and is also an additive of novel biochemical drugs, drug intermediates and high-grade cosmetics. It can enhance immunity and treat various inflammations. GlcNAc is an important precursor for the synthesis of bifidus factors and hyaluronic acid in the human body, and compared with hyaluronic acid, GlcNAc is a monomer with a small molecular weight, is very easily absorbed by the skin, and can provide nutrition, moisture and anti-free radicals when applied to cosmetics, so GlcNAc is often used for the production of high-grade cosmetics, and the addition amount of GlcNAc in the cosmetics is generally 0.1-5%. At present, various skin care products containing GlcNAc are available in domestic markets, the highest addition amount reaches 4%, and the effect is good.
Disclosure of Invention
An object of the present invention is to solve at least the above problems and to provide at least the advantages described later.
The invention also aims to provide the saccharomyces cerevisiae and a method for producing the glucosamine by the saccharomyces cerevisiae, which optimize the fermentation process of the self-made engineering strains and improve the yield of the glucosamine.
To achieve these objects and other advantages in accordance with the present invention, there is provided a Saccharomyces cerevisiae H158-1C deposited at the China general microbiological culture Collection center with accession numbers: CGMCC No.11735, the preservation time is as follows: 11/25/2015.
A method for producing glucosamine by using saccharomyces cerevisiae comprises the following steps:
step one, seed culture: inoculating the saccharomyces cerevisiae on a slant culture medium containing kanamycin sulfate, culturing for 24-28 h at the temperature of 30-37 ℃, inoculating on a seed culture medium, and culturing to OD at the temperature of 30-37 ℃ and the rotating speed of 1100-2000 r/min600When the value is 2-3, obtaining a seed culture solution;
step two, seed fermentation: inoculating the planting culture solution prepared in the second step onto a fermentation culture medium, and fermenting for 18-20 hours at the temperature of 35-40 ℃ and the rotating speed of 200-220 r/min to obtain a fermentation solution;
wherein the volume of the seed culture solution inoculated to the fermentation culture medium is 1-5% of the volume of the fermentation culture medium;
adding kanamycin sulfate with the final concentration of 70 mug/mL into the fermentation medium before inoculation, and controlling the residue to be 2.0%;
when OD of the bacterial body600When the concentration is 0.6, 5g/L of lactose is added into the fermentation medium;
fermenting for 2-10 h in seeds and obtaining the OD of thalli600When the cell growth rate is 2-3, the fermentation medium is fed with glucose in an initial exponential manner, and the cell growth rate is controlled to be 0.2h-1;
The dissolved oxygen regulating strategy in seed fermentation is as follows: when the seeds are fermented for 0-2 h, 3-8 h, 9-12 h and 13-18 h, respectively controlling the dissolved oxygen amount to be 20%, 30%, 40% and 30%, the ventilation volume per ventilation to be 10vvm and the gas temperature to be 35-37 ℃;
and step three, purifying and crystallizing the fermentation liquor obtained in the step two to obtain the glucosamine.
Preferably, in the method for producing glucosamine by saccharomyces cerevisiae, in the first step, the slant culture medium comprises: 10-15 g/L of tryptone, 5-10 g/L, NaCl 10-15 g/L of yeast powder, 20-25 g/L of agar powder and 40-50 mg/L of kanamycin sulfate;
the pH value of the slant culture medium is 6.5-7.5, and the slant culture medium is sterilized at 0.1MPa for 25-30 min.
Preferably, in the method for producing glucosamine by saccharomyces cerevisiae, in the first step, the seed culture medium comprises: 50-60 g/L of D-glucosamine hydrochloride, 25-30 g/L of calcium carbonate, 10-15 g/L of monopotassium phosphate, 15-20 g/L of magnesium sulfate heptahydrate, 0-15 g/L of sodium nitrate, 10-15 g/L of yeast extract and 1-3 ml/L of corn steep liquor;
the pH value of the seed culture medium is 6.5-7.5, and the seed culture medium is sterilized at 0.1Mpa for 25-30 min.
Preferably, in the method for producing glucosamine by saccharomyces cerevisiae, in the second step, the fermentation medium comprises: 50-90 g/L of glucose, 10-20 g/L of lactose, 10-15 g/L of calcium carbonate, 15-20 g/L of monopotassium phosphate, 5-7 g/L of magnesium sulfate heptahydrate, 5-8 g/L of sodium nitrate, 5-10 g/L of yeast extract and 3-5 ml/L of corn steep liquor;
the pH value of the fermentation medium is 6.5-7.5, and the fermentation medium is sterilized at 0.1Mpa for 25-30 min.
Preferably, in the method for producing glucosamine by saccharomyces cerevisiae, kanamycin sulfate with a final concentration of 50-70 μ g/mL is added to the fermentation medium before inoculating the seed culture solution in the second step, and the residual amount of kanamycin sulfate is 20 μ g/mL.
Preferably, in the method for producing glucosamine by saccharomyces cerevisiae, the third step is specifically:
centrifuging the fermentation liquor prepared in the step two for 15-20 min at the rotating speed of 7500-8000 rpm, taking the supernatant, heating for 15-20 min at 90-100 ℃, centrifuging for 20-25 min at the rotating speed of 12000-13000 rpm, taking the supernatant to obtain stock solution,
decoloring the stock solution by using diatomite, adopting ammonium sulfate at the temperature of 30-35 ℃ as an eluent, stopping elution when the concentration of an ammonium sulfate solution is 0.7-1.0 mol/L to obtain an initial filtrate, adsorbing and filtering the initial filtrate by using styrene strong acid cationic resin, eluting by using absolute ethyl alcohol with the same volume as the initial filtrate when the sample introduction flow rate is 3.19BV/h and the elution flow rate is 3.8BV/h to obtain a final filtrate, standing the final filtrate at the temperature of 4 ℃ for 6-10 h, and performing suction filtration to obtain the glucosamine acid crystal.
The invention at least comprises the following beneficial effects: firstly, the invention is a microbial fermentation method for preparing glucosamine, is an important hexosamine, can effectively act on cartilage tissues to treat rheumatoid arthritis, is considered as a natural and harmless food and health-care product ingredient, and has wide market application prospect; secondly, the invention optimizes the fermentation process of the self-made engineering strain, determines that the yield of the glucosamine is obviously improved by implementing a lactose feeding strategy and a staged dissolved oxygen control strategy in the fermentation process, the intracellular and extracellular yields of the glucosamine are not less than 134.7g/L, the adsorption rate of the purification is not less than 95%, the elution rate is not less than 98%, the purity of the glucosamine is more than 98%, and the domestic advanced level is reached.
Additional advantages, objects, and features of the invention will be set forth in part in the description which follows and in part will become apparent to those having ordinary skill in the art upon examination of the following or may be learned from practice of the invention
Drawings
FIG. 1 is a flow chart of glucosamine production by Saccharomyces cerevisiae according to the present invention.
Detailed Description
The present invention is further described in detail below with reference to the attached drawings so that those skilled in the art can implement the invention by referring to the description text.
It will be understood that terms such as "having," "including," and "comprising," as used herein, do not preclude the presence or addition of one or more other elements or groups thereof.
Examples 1,
The Saccharomyces cerevisiae H158-1C is classified and named as Saccharomyces cerevisiae, and is preserved in China general microbiological culture Collection center with the preservation number of: CGMCC No.11735, the preservation time is as follows: 11 month and 25 days 2015; the address of the preservation unit is as follows: xilu No.1, Beijing, Chaoyang, Beijing, and institute for microbiology, China academy of sciences.
Examples 2,
As shown in FIG. 1, the present invention provides a method for producing glucosamine using Saccharomyces cerevisiae as described in example 1, comprising the steps of:
step one, seed culture: inoculating the Saccharomyces cerevisiae to a slant culture medium containing kanamycin sulfate, culturing at 30 deg.C for 24 hr, inoculating to a seed culture medium, and culturing at 30 deg.C and 1100r/min to OD600When the value is 2, obtaining a seed culture solution;
step two, seed fermentation: inoculating the planting culture solution prepared in the second step onto a fermentation culture medium, fermenting for 18h at the temperature of 35 ℃ and the rotating speed of 200r/min,
wherein the volume of the seed culture solution inoculated on the fermentation culture medium is 1 percent of the volume of the fermentation culture medium;
adding kanamycin sulfate with the final concentration of 70 mug/mL into the fermentation medium before inoculation, and controlling the residue to be 2.0%;
when OD of the bacterial body600When the concentration is 0.6, 5g/L of lactose is added into the fermentation medium;
fermenting for 2h in seed and the OD of thallus600When the cell growth rate is 2, the fermentation medium is fed with glucose in an initial exponential manner, and the cell growth rate is controlled to be 0.2h-1;
The dissolved oxygen regulating strategy in seed fermentation is as follows: when the seeds are fermented for 0-2 h, 3-8 h, 9-12 h and 13-18 h, respectively controlling the dissolved oxygen amount to be 20%, 30%, 40% and 30%, the ventilation volume of each ventilation to be 10vvm, and the gas temperature to be 35 ℃;
and step three, purifying and crystallizing the fermentation liquor obtained in the step two to obtain the glucosamine.
Wherein,
in step one, the slant medium comprises: 10g/L of tryptone, 5g/L, NaCl 10g/L of yeast powder, 20g/L of agar powder and 40mg/L of kanamycin sulfate; the slant culture medium has pH of 6.5, and is sterilized at 0.1Mpa for 30 min.
In the first step, the seed culture medium comprises: 50g/L of D-glucosamine hydrochloride, 25g/L of calcium carbonate, 10g/L of monopotassium phosphate, 15g/L of magnesium sulfate heptahydrate, 0g/L of sodium nitrate, 10g/L of yeast extract and 1ml/L of corn steep liquor; the pH of the seed culture medium was 6.5, and sterilized at 0.1MPa for 25 min.
In the second step, the fermentation medium comprises: 50g/L of glucose, 10g/L of lactose, 10g/L of calcium carbonate, 15g/L of monopotassium phosphate, 5g/L of magnesium sulfate heptahydrate, 5g/L of sodium nitrate, 5g/L of yeast extract and 3ml/L of corn steep liquor; the pH of the fermentation medium was 6.5, and sterilized at 0.1MPa for 25 min.
In the second step, 50 mug/mL kanamycin sulfate is added to the fermentation medium before inoculating the seed culture solution, and the residual amount of the kanamycin sulfate is 20 mug/mL.
The third step is specifically as follows:
centrifuging the fermentation liquor prepared in the seed fermentation process at 7500rpm for 15min to remove cell thallus, collecting supernatant, heating at 90 deg.C for 15min, centrifuging at 12000rpm for 20min to remove impure protein in the supernatant, and collecting supernatant to obtain stock solution;
decolorizing the stock solution with diatomite, adopting ammonium sulfate at the temperature of 30 ℃ as an eluent, stopping elution when the concentration of an ammonium sulfate solution is 0.7mol/L to obtain an initial filtrate, adsorbing and filtering the initial filtrate by using styrene strong acid cation resin, eluting by using absolute ethyl alcohol with the same volume as the initial filtrate when the sample introduction flow rate is 3.19BV/h and the elution flow rate is 3.8BV/h to obtain a final filtrate, standing the final filtrate at the temperature of 4 ℃ for 6h, and performing suction filtration to obtain the glucosamine acid crystal, wherein the purity of the glucosamine acid crystal is more than 98%.
Examples 3,
The invention provides a method for producing glucosamine by using saccharomyces cerevisiae as described in embodiment 1, which is characterized by comprising the following steps:
step one, seed culture: inoculating the Saccharomyces cerevisiae onto slant culture medium containing kanamycin sulfate, culturing at 37 deg.C for 28 hr, inoculating onto seed culture medium, and culturing at 37 deg.C and 2000r/min to OD600When the value is 3, obtaining a seed culture solution;
step two, seed fermentation: inoculating the planting culture solution prepared in the second step onto a fermentation culture medium, fermenting for 20h at the temperature of 40 ℃ and the rotating speed of 220r/min,
wherein the volume of the seed culture solution inoculated on the fermentation culture medium is 5 percent of the volume of the fermentation culture medium;
adding kanamycin sulfate with the final concentration of 70 mug/mL into the fermentation medium before inoculation, and controlling the residue to be 2.0%;
when OD of the bacterial body600When the concentration is 0.6, 5g/L of lactose is added into the fermentation medium;
fermenting for 10h in seed and the OD of thallus600When the angle is 3, the directionThe fermentation medium is added with glucose at the beginning of exponential flow, and the specific growth rate of the cells is controlled to be 0.2h-1;
The dissolved oxygen regulating strategy in seed fermentation is as follows: when the seeds are fermented for 0-2 h, 3-8 h, 9-12 h and 13-18 h, respectively controlling the dissolved oxygen amount to be 20%, 30%, 40% and 30%, the ventilation volume of each ventilation to be 10vvm, and the gas temperature to be 37 ℃;
and step three, purifying and crystallizing the fermentation liquor obtained in the step two to obtain the glucosamine.
Wherein,
in the first step, a slant culture medium contains 15g/L of tryptone, 10g/L, NaCl 15g/L of yeast powder, 25g/L of agar powder and 50mg/L of kanamycin sulfate; the slant culture medium has pH of 7.5, and is sterilized at 0.1MPa for 30 min.
In the first step, the seed culture medium comprises: 60g/L of D-glucosamine hydrochloride, 30g/L of calcium carbonate, 15g/L of monopotassium phosphate, 20g/L of magnesium sulfate heptahydrate, 15g/L of sodium nitrate, 15g/L of yeast extract and 3ml/L of corn steep liquor;
the pH of the seed culture medium was 7.5, and sterilized at 0.1MPa for 30 min.
In the second step, the fermentation medium comprises: 90g/L glucose, 20g/L lactose, 15g/L calcium carbonate, 20g/L potassium dihydrogen phosphate, 7g/L magnesium sulfate heptahydrate, 8g/L sodium nitrate, 10g/L yeast extract and 5ml/L corn steep liquor.
In the second step, 50 mug/mL kanamycin sulfate is added to the fermentation medium before inoculating the seed culture solution, and the residual amount of the kanamycin sulfate is 20 mug/mL.
The third step is specifically as follows:
centrifuging the fermentation liquor prepared in the seed fermentation process at 8000rpm for 20min to remove cell thallus, collecting supernatant, heating at 100 deg.C for 15min, centrifuging at 13000rpm for 25min to remove impure protein in the supernatant, and collecting supernatant to obtain stock solution;
decolorizing the stock solution with diatomite, adopting ammonium sulfate at the temperature of 35 ℃ as an eluent, stopping elution when the concentration of an ammonium sulfate solution is 1.0mol/L to obtain an initial filtrate, adsorbing and filtering the initial filtrate by using a styrene strong acid cation resin, eluting by using absolute ethyl alcohol with the same volume as the initial filtrate when the sample introduction flow rate is 3.19BV/h and the elution flow rate is 3.8BV/h to obtain a final filtrate, standing the final filtrate at the temperature of 4 ℃ for 10h, and performing suction filtration to obtain an aminogluconic acid crystal; the purity of the glucosamine acid crystal is more than 98 percent.
Examples 4,
Screening of Saccharomyces cerevisiae
Fermentation strain: activating Saccharomyces Cerevisiae on a fresh plate culture medium, inoculating a loopful into a 10ml fermentation culture medium, culturing at 30 ℃ and at the rotating speed of 120rm, sampling every 24H, detecting the consumption of D-glucosamine and the generation condition of D-glucosamine by adopting paper chromatography to screen out a target strain capable of effectively oxidizing a substrate and accumulating the glucosamine, and after repeated screening for many times, the total yield of the glucosamine reaches 25g +/-1/L after fermenting for 24H +/-4H, and the strain is named as Saccharomyces Cerevisiae genetically engineered bacteria (Saccharomyces Cerevisiae) H158-1C (strain preservation number: CGMCC No: 11735).
II, preparing glucosamine
Seed culture: selecting a loop from a preserved and constructed saccharomyces cerevisiae 158-1C slant test tube by using an inoculating loop under the aseptic condition of an ultra-clean workbench, drawing a line on the surface of a slant culture medium containing kanamycin sulfate, placing the slant culture medium in a constant temperature incubator at 35-37 ℃ for inverted culture for 24-28 h, adopting a 250mL triangular flask for seed culture, filling 50mL seed culture medium into the triangular flask, selecting the saccharomyces cerevisiae into the triangular flask, culturing at 35 ℃, 1600r/min for 11h and OD (origin-destination) for 11h600When the value is 3, a seed culture solution is obtained and taken out for standby.
Seed fermentation: inoculating the seed culture solution into a 500mL triangular flask (containing 50mL fermentation medium) according to the inoculation amount of 1-2% (v/v), and culturing at 37 deg.C for 210r/min until the thallus OD600When the concentration reached 0.6, 5g/L lactose was added, kanamycin sulfate was added to the fermentation medium at a final concentration of 70. mu.g/mL before use, the residue was controlled to 2.0%, and the medium was cultured for 20 hours. Glucose feeding mode: no glucose is fed for 0-2 h; 2 to 10 hours and OD600The glucose is added into the cell in an exponential manner, and the specific growth rate mu of the cell is controlled when the value is about 2.5setIs 0.2h-1. Dissolved oxygen regulation strategy:0-2 h, and the DO (dissolved oxygen) value is 20%; 3-8 h, and the DO value is 30%; 9-12 h, and the DO value is 40%; 13-18 h, the DO value is 30%, the ventilation volume is controlled to be 1.0vvm in the fermentation process, the temperature is 36 ℃, and the constant-speed feeding is carried out.
Purification and crystallization: centrifuging the fermentation liquid prepared in the seed fermentation process at 7700rpm for 18min to remove cell thallus, collecting supernatant, heating at 95 deg.C for 18min, centrifuging at 12500rpm for 23min to remove impure protein in the supernatant, collecting supernatant to obtain stock solution,
decolorizing the stock solution with diatomite, adopting ammonium sulfate at the temperature of 33 ℃ as an eluent, stopping elution when the concentration of an ammonium sulfate solution is 0.8mol/L to obtain an initial filtrate, adopting styrene strong acid cation resin for adsorption filtration of the initial filtrate, adopting absolute ethyl alcohol with the same volume as the initial filtrate for elution when the sampling flow rate is 3.19BV/h and the elution flow rate is 3.8BV/h to obtain a final filtrate, standing the final filtrate at the temperature of 4 ℃ for 8h, and performing suction filtration to obtain the glucosamine acid crystal. The adsorption rate was 95.43%, and the elution rate was 98.47%; the purity of the glucosamine acid crystal is more than 98 percent.
Wherein the slant culture medium comprises: 13g/L of tryptone, 7g/L, NaCl13g/L of yeast powder, 23g/L of agar powder and 45mg/L of kanamycin sulfate; the slant culture medium has pH of 7, and is sterilized at 0.1MPa for 30 min.
The seed culture medium comprises: 55g/L of D-glucosamine hydrochloride, 27g/L of calcium carbonate, 13g/L of monopotassium phosphate, 17g/L of magnesium sulfate heptahydrate, 13g/L of sodium nitrate, 13g/L of yeast extract and 2ml/L of corn steep liquor; the pH of the seed culture medium was 7, and sterilized at 0.1MPa for 28 min.
The fermentation medium comprises: 70g/L of glucose, 15g/L of lactose, 13g/L of calcium carbonate, 18g/L of monopotassium phosphate, 6g/L of magnesium sulfate heptahydrate, 7g/L of sodium nitrate, 8g/L of yeast extract and 4ml/L of corn steep liquor; the fermentation medium has pH of 7, and is sterilized at 0.1MPa for 28 min.
And (3) detection:
the detection method of intracellular GlcN comprises the following steps: adding 5.0mL of fermentation liquid into a 5mL centrifuge tube, centrifuging for 8min at 5000r/min, discarding the supernatant, washing the thalli with sterile water for 3 times, treating the thalli with 10mL of 6mol/L hydrochloric acid in a 100 ℃ water bath for 3h, neutralizing the thalli with 10mol/L NaOH to pH7.0, cooling the thalli on ice to room temperature, diluting to 50mL, adding 0.5mL of acetylacetone reagent into the thalli, treating the thalli in a 90 ℃ water bath for 1h, cooling the thalli to the room temperature, slowly adding 10mL of 96% (v/v) ethanol, then adding 1.0mL of DMAB (dimethylamino borane) reagent (DMAB reagent, weighing 1.6g of DMAB, dissolving the DMAB in 30mL 30m L concentrated hydrochloric acid and 30mL 96% ethanol), and uniformly mixing. After mixing, the mixture was left at room temperature for 1 hour, and colorimetric at 530nm, and intracellular GlcN yield was calculated according to the standard curve.
The method for detecting extracellular GlcN comprises the following steps: adding 5.0mL of fermentation liquor into a 5mL centrifuge tube, centrifuging at 8000r/min for 8min, adding 1.0mL of acetylacetone reagent into 0.5mL of centrifuged supernatant, treating in 90 ℃ water bath for 1h, cooling to room temperature, slowly adding 10mL of 96% (v/v) ethanol, then adding 1.0mL of DMAB reagent, and uniformly mixing. After mixing, the mixture was left at room temperature for 1 hour, and the extracellular GlcN yield was calculated from a standard curve by color comparison at 530 nm.
The yield of extracellular glucosamine is 7.21 +/-0.08 g/L, and the yield of intracellular glucosamine is 128.51 +/-0.09 g/L.
While embodiments of the invention have been described above, it is not limited to the applications set forth in the description and the embodiments, which are fully applicable in various fields of endeavor to which the invention pertains, and further modifications may readily be made by those skilled in the art, it being understood that the invention is not limited to the details shown and described herein without departing from the general concept defined by the appended claims and their equivalents.
Claims (5)
1. The method for producing glucosamine by saccharomyces cerevisiae is characterized in that the saccharomyces cerevisiae is preserved in China general microbiological culture Collection center with the preservation number of: CGMCC No.11735, the preservation time is as follows: 11 month and 25 days 2015; the method comprises the following steps:
step one, seed culture: inoculating the saccharomyces cerevisiae on a slant culture medium containing kanamycin sulfate, culturing for 24-28 h at the temperature of 30-37 ℃, inoculating on a seed culture medium, and culturing to OD at the temperature of 30-37 ℃ and the rotating speed of 1100-2000 r/min600When the value is 2-3, obtaining a seed culture solution;
step two, seed fermentation: inoculating the planting culture solution prepared in the second step onto a fermentation culture medium, and fermenting for 18-20 hours at the temperature of 35-40 ℃ and the rotating speed of 200-220 r/min to obtain a fermentation solution;
wherein the volume of the seed culture solution inoculated to the fermentation culture medium is 1-5% of the volume of the fermentation culture medium;
adding kanamycin sulfate with the final concentration of 70 mug/mL into the fermentation medium before inoculation, and controlling the residue to be 2.0%;
when OD of the bacterial body600When the concentration is 0.6, 5g/L of lactose is added into the fermentation medium;
fermenting for 2-10 h in seeds and obtaining the OD of thalli600When the cell growth rate is 2-3, the fermentation medium is fed with glucose in an initial exponential manner, and the cell growth rate is controlled to be 0.2h-1;
The dissolved oxygen regulating strategy in seed fermentation is as follows: when the seeds are fermented for 0-2 h, 3-8 h, 9-12 h and 13-18 h, respectively controlling the dissolved oxygen amount to be 20%, 30%, 40% and 30%, the ventilation volume of each ventilation to be 10vvm, and the gas temperature to be 35-37 ℃;
step three, purifying and crystallizing the fermentation liquor prepared in the step two to obtain glucosamine;
the third step is specifically as follows:
centrifuging the fermentation liquor prepared in the step two for 15-20 min at the rotating speed of 7500-8000 rpm, taking the supernatant, heating for 15-20 min at 90-100 ℃, centrifuging for 20-25 min at the rotating speed of 12000-13000 rpm, taking the supernatant to obtain stock solution,
decoloring the stock solution by using diatomite, adopting ammonium sulfate at the temperature of 30-35 ℃ as an eluent, stopping elution when the concentration of an ammonium sulfate solution is 0.7-1.0 mol/L to obtain an initial filtrate, adsorbing and filtering the initial filtrate by using styrene strong acid cationic resin, eluting by using absolute ethyl alcohol with the same volume as the initial filtrate when the sample introduction flow rate is 3.19BV/h and the elution flow rate is 3.8BV/h to obtain a final filtrate, standing the final filtrate at the temperature of 4 ℃ for 6-10 h, and performing suction filtration to obtain the glucosamine acid crystal.
2. The method for producing glucosamine by saccharomyces cerevisiae according to claim 1, wherein in the first step, the slant culture medium comprises: 10-15 g/L of tryptone, 5-10 g/L, NaCl 10-15 g/L of yeast powder, 20-25 g/L of agar powder and 40-50 mg/L of kanamycin sulfate;
the pH value of the slant culture medium is 6.5-7.5, and the slant culture medium is sterilized at 0.1MPa for 25-30 min.
3. The method for producing glucosamine by saccharomyces cerevisiae according to claim 1, wherein in the first step, the seed culture medium comprises: 50-60 g/L of D-glucosamine hydrochloride, 25-30 g/L of calcium carbonate, 10-15 g/L of monopotassium phosphate, 15-20 g/L of magnesium sulfate heptahydrate, 0-15 g/L of sodium nitrate, 10-15 g/L of yeast extract and 1-3 ml/L of corn steep liquor;
the pH value of the seed culture medium is 6.5-7.5, and the seed culture medium is sterilized at 0.1Mpa for 25-30 min.
4. The method for producing glucosamine by saccharomyces cerevisiae according to claim 1, wherein in the second step, the fermentation medium comprises: 50-90 g/L of glucose, 10-20 g/L of lactose, 10-15 g/L of calcium carbonate, 15-20 g/L of monopotassium phosphate, 5-7 g/L of magnesium sulfate heptahydrate, 5-8 g/L of sodium nitrate, 5-10 g/L of yeast extract and 3-5 ml/L of corn steep liquor;
the pH value of the fermentation medium is 6.5-7.5, and the fermentation medium is sterilized at 0.1Mpa for 25-30 min.
5. The method for producing glucosamine by saccharomyces cerevisiae according to claim 1 or 4, wherein kanamycin sulfate is added to the fermentation medium in the second step to a final concentration of 50-70 μ g/mL before inoculating the seed culture solution, and the residual amount of kanamycin sulfate is 20 μ g/mL.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610168668.6A CN105695350B (en) | 2016-03-23 | 2016-03-23 | Saccharomyces cerevisiae and method for producing glucosamine by using saccharomyces cerevisiae |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610168668.6A CN105695350B (en) | 2016-03-23 | 2016-03-23 | Saccharomyces cerevisiae and method for producing glucosamine by using saccharomyces cerevisiae |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105695350A CN105695350A (en) | 2016-06-22 |
CN105695350B true CN105695350B (en) | 2020-02-07 |
Family
ID=56231655
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610168668.6A Active CN105695350B (en) | 2016-03-23 | 2016-03-23 | Saccharomyces cerevisiae and method for producing glucosamine by using saccharomyces cerevisiae |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105695350B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108410783B (en) * | 2018-05-29 | 2020-11-03 | 成都本则生科技有限公司 | Method for producing glucosamine by culturing escherichia coli and fermenting |
CN111518709B (en) * | 2020-05-06 | 2021-03-23 | 广州市巧美化妆品有限公司 | Saccharomyces cerevisiae strain YWY-1, fermentation filtrate prepared by using the strain, toning lotion prepared by using the filtrate and preparation method |
CN113416761B (en) * | 2021-07-19 | 2022-07-29 | 合肥康诺生物制药有限公司 | Method for preparing NMN by fermentation culture method |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005056570A2 (en) * | 2003-12-08 | 2005-06-23 | Cargill, Inc. | Production of amino sugars |
CN102268399A (en) * | 2011-06-27 | 2011-12-07 | 江南大学 | High-yield glucosamine engineering bacterium with nagE being knocked-out by homologous recombination and construction method thereof |
CN102286420A (en) * | 2011-06-27 | 2011-12-21 | 江南大学 | High-glucosamine-yield engineering bacterium with manX knocked out by homologous recombination and construction method thereof |
CN103429731A (en) * | 2008-10-20 | 2013-12-04 | Cj第一制糖株式会社 | Corynebacterium genus microorganism with ability to produce N-acetyl glucosamine and method for producing N-acetyl glucosamine or glucosamine using same |
-
2016
- 2016-03-23 CN CN201610168668.6A patent/CN105695350B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005056570A2 (en) * | 2003-12-08 | 2005-06-23 | Cargill, Inc. | Production of amino sugars |
CN103429731A (en) * | 2008-10-20 | 2013-12-04 | Cj第一制糖株式会社 | Corynebacterium genus microorganism with ability to produce N-acetyl glucosamine and method for producing N-acetyl glucosamine or glucosamine using same |
CN102268399A (en) * | 2011-06-27 | 2011-12-07 | 江南大学 | High-yield glucosamine engineering bacterium with nagE being knocked-out by homologous recombination and construction method thereof |
CN102286420A (en) * | 2011-06-27 | 2011-12-21 | 江南大学 | High-glucosamine-yield engineering bacterium with manX knocked out by homologous recombination and construction method thereof |
Non-Patent Citations (1)
Title |
---|
酿酒酵母S.cerevisiae高密度培养条件优化研究;王颖 等;《工业微生物》;20070228;第37卷(第1期);摘要 * |
Also Published As
Publication number | Publication date |
---|---|
CN105695350A (en) | 2016-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6292725B2 (en) | Lipopolysaccharide, lipopolysaccharide production method and lipopolysaccharide compound | |
Roca et al. | Production of yeast chitin–glucan complex from biodiesel industry byproduct | |
CN101643709B (en) | Bacterial strain and method for producing antibiotic avilamycin special for animal | |
CN105695350B (en) | Saccharomyces cerevisiae and method for producing glucosamine by using saccharomyces cerevisiae | |
KR101413784B1 (en) | Preparation method of low molecular weight sodium hyaluronate | |
CN102399837B (en) | Method for synthesizing acarbose through microbial fermentation | |
CN108410783B (en) | Method for producing glucosamine by culturing escherichia coli and fermenting | |
WO2012016445A1 (en) | Bacillus subtilis strain and uses thereof | |
CN112220814A (en) | Green plum blossom fermented product for relieving gout | |
CN101333500B (en) | Red rice products and applications thereof for preparing hypotensor | |
CN1515678A (en) | Preparation method of natamycin | |
CN107955825B (en) | A method for preparing sweetener composition containing D-psicose as main ingredient | |
CN109207536B (en) | Method for increasing content of milbemycin A3 in milbemycin fermentation product | |
CN108484692B (en) | Method for efficiently extracting glucosamine from fermentation liquor | |
KR100351754B1 (en) | Animal feed additive comprising chitin, chitosan, chito-oligosaccharide and et al., products of microorganism fermentation | |
EP3182981B1 (en) | Process for the production of isomaltooligosaccharides | |
KR101627806B1 (en) | The culturing method for increasing immune-enhancing activity in Lactobacillus spp. | |
JPH0689012B2 (en) | CL-1577-B (bottom 4) compound and its production method | |
CN109504713A (en) | The method and application of high ester bond humic acid preparation are prepared using Clostridium beijerinckii | |
CN108060192B (en) | Fermentation medium for improving fermentation level of meleumycin and feeding method | |
CN112662719A (en) | Production method of abamectin, product and application thereof | |
CN111903845A (en) | Method for producing biological feed with function of replacing antibiotics by utilizing molasses | |
CN115777949B (en) | Dietary fiber composition based on intestinal flora intestinal characteristics and preparation method and application thereof | |
CN114875104B (en) | Mulberry leaf ferment stock solution and preparation method and application thereof | |
CN116059223B (en) | Application of tyrosol-beta-galactoside in regulating intestinal microorganisms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |